63
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Chronic airflow limitation in developing countries: burden and priorities

, , , , &
Pages 141-150 | Published online: 20 Oct 2022

References

  • AdamsRJFuhlbriggeAFinkenelsteinJA2001Impact of inhaled anti-inflammatory therapy on hospitalisations and emergency department visits for children with asthmaPediatrics1077061111335748
  • AdamsNPBestallJBMaloufR2005aBeclomethasone versus placebo for chronic asthmaCochrane Database Syst Rev1CD00273815674896
  • AdamsNPBestallJMLassersonTJ2005bFluticasone versus beclomethasone or budesonide for chronic asthma in adults and childrenCochrane Database Syst Rev2CD002310
  • AdamsNPJonesPW2006The dos-response characteristics of inhaled corticosteroids when used to treat asthma: An overview of Cochrane systematic reviewsRespir Med100129730616806876
  • Aït-KhaledNAureganGBencharifN2000Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countriesInt J Tuberc Lung Dis42687110751075
  • Aït-KhaledNEnarsonDABousquetJ2001Chronic respiratory diseases in developing countries: the burden and strategies for prevention and managementBull World Health Organ79971911693980
  • Ait- KhaledNChauletPEnarsonDA2002Clinical management of clinical obstructive pulmonary diseaseSimilowskiTDerennePEpidemiology and management of stable chronic obstructive pulmonary disease in AfricaNew YorkMarcel Dekker43100730
  • Aït-KhaledNEnarsonDA2005Management of asthmaA guide to the essentials of good clinical practice2nd edParis, FranceInternational Union Against Tuberculosis and Lung DiseaseURL: http//:www.iuatld.org
  • Aït-KhaledNEnarsonDABencharifN2006aImplementation of asthma guidelines in health centres of several developing countriesInt J Tuberc Lung Dis101049
  • Aït-KhaledN2006Favoriser l’accessibilité aux médicaments essentiels de l’asthmeRev Mal Resp2310S7610S79
  • Aït-KhaledNEnarsonDABencharifN2006bTreatment outcome of asthma after one year follow-up in health centres of several developing countriesInt J Tuberc Lung Dis1091116
  • AmosA1996Women and smoking: a global issueWorld Health Stat Q4912733
  • AnyangweSCMtongaCChirwaB2006Health inequities, environmental insecurity and the attainments of the millennium development goals in sub-Saharan Africa: The case study of ZambiaInt J Environ Res Public Health32172716968967
  • AppletonSPoolePSmithB2001Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitationCochrane Database Syst Rev4CD001104
  • AppletonSJonesTPooleP2006Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev2CD00138716625543
  • BarrRGBourbeauJCamargoCA2005Tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev2CD00287615846642
  • BayerRStuberJ2006Tobacco control, stigma, and public health : rethinking the relationsAm J Public Health96475016317199
  • BeasleyRKeilUVon MutiusEISAAC Steering Committee1998Worldwide variation in the prevalence of asthma, allergic rhinoconjonctivitis and atopic eczema symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)Lancet3511225329643741
  • BakkeSBasteVHanoaR1991Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agentsThorax46863701792631
  • BarisEEzzatiM2004Should interventions to reduce respirable pollutants be linked to tuberculosis control programmes?BMJ3291090315528622
  • BatemanEDBousheyHABousquetJGOAL Investigators Group2004Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control StudyAm J Respir Crit Care Med1708364415256389
  • BilloN2004Do we need an asthma drug facility?Int J Tuberc Lung Dis839115141728
  • BilloN2006ADF from concept to realityInt J Tuber Lung Dis10709
  • BousquetJNdiayeMAït-KhaledN2003Management of chronic respiratory and allergic diseases in developing countries. Focus on sub-Saharan AfricaAllergy582658312708972
  • BousquetJVan CauwenbergPKhaltaevN2001ARIA workshop report in collaboration with WHOJ Allergy Clin Immunol1085 SupplS14733411707753
  • CalverleyPMPauwelsRVestboJTrial of Inhaled steroids and long acting beta 2 agonists. study group2003aCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet3614495612583942
  • CalverleyPMBoonsawatWCsekeZ2003bMaintenance therapy with budesonide and fomoterol in chronic obstructive diseaseEur Respir J229121914680078
  • CastroMZimmermanNACrockerS2003Asthma intervention program prevents readmissions in high healthcare usersAm J Respir Crit Care16810959
  • Chan-YeungMAït-KhaledNWhiteN2004Management of COPD in Asia and AfricaInt Union Tuberc Lung Dis815970
  • ChappleAZieblandSMcPhersonA2004Stigma, shame, and blame experienced by patients with lung cancer: qualitative studyBMJ328147015194599
  • EnarsonDAAït-KhaledN1999Cultural barriers to asthma managementPediatr Pulmonol2829730010497379
  • EnarsonDA1998Lung health and the International Union Against Tuberculosis and Lung DiseaseInt J Tuberc Lung Dis2969709869109
  • [ECRHS] European Community Respiratory Health Survey1996Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medications in the European Community Respiratory Health Survey (ECRHS)Eur Respir J9687958726932
  • FioreMCBaileyWCCohenSJ2000Treating tobacco use and dependance Clinical Practice GuidelineRockville, MDU.S. Department of Health and Human Services
  • FriedmanMSerbyCWHillemanDE1999Pharmacoeconomic Evaluation of a combination of Ipratropium Plus Albuterol Compared With Ipratropium and albuterol alone in COPDChest1156354110084468
  • FournierMTonnelABHoussetB2005Economic burden of COPD in France: The Scope Study [French]Rev Mal Respir222475516092163
  • GartlehnerGHansenRACarsonSS2006Efficacy and safety of inhaled corticosteroids in patients with COPD. A systematic review and meta-analysis of health outcomesAnn Fam Med42536216735528
  • GeldersSEwenMNoguchiN2006Price, availability and affordability. An international comparison of chronic disease medicines [online]. Accessed on February 2, 2007. Geneva: WHO, Health Action International. URL: http://mednet3.who.int/medprices/CHRONIC.pdf
  • [GINA] Global Initiative for Asthma2005Global strategy for asthma management and prevention. NHLBI/WHO workshop report [online]. Accessed on February 2, 2007. NIH publication number 95–3659. Revision 2005. URL: http://www.gina.com/
  • [GOLD] Global Initiative for Chronic Obstructive Lung Disease2005Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [online]. Accessed on February 2, 2007. NIH, NHLBI publication Number 2701, April 2001. Updated 2005. URL: http://www.goldcopd.org/
  • GulsvikA1979Prevalence and manifestations of obstructive lung disease in the city of OsloScand J Respir Dis6028696524075
  • HalpinDM2006Heath economics of chronic obstructive pulmonary diseaseProc Am Thorac322733
  • LaiCKWDe GuiaTSKimYY2003Asthma control in Asia-Pacific StudyJ Allergy Clin Immunol11126312589343
  • LallooUGMclvorRA2006Management of chronic asthma in adults in diverse regions of the worldInt Union Tuberc Lung Dis1047483
  • LangePGrothSNyboeJ1989Chronic obstructive lung disease in Copenhagen: cross-sectional, epidemiological aspectsJ Intern Med22625322787829
  • LopezADMathersCDEzzatiM2006Global and regional burden of diseases and risk factors, 2001: systematic analysis of population health dataLancet36717475716731270
  • ManninoDMGagnonRCPettyTL2000Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994Arch Intern Med1601683910847262
  • Marco-JordanLMartin-BerraJInigoMC1998Enfermedad pulmonar obstructiva cronica en la poblacion general: estudio epidemiologico realizado en GuipuzcoaArch Bronconeumol342379580182
  • MawarNSahaSPanditA2005The third phase of HIV pandemic: social consequences of HIV/AIDS stigma and discrimination and future needsIndian J Med Resp12247184
  • MenezesAMPerez-PadillaRJardimJB2005Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet36618758116310554
  • [MHM and AMMMTS] Ministry of Health of Malaysia, Academy of Medicine of Malaysia and Malaysian Thoracic Society1999Guidelines in the management of chronic obstructive pulmonary disease. A consensus statementMed J Malaysia5438740111045071
  • MuellerREKebleDLPlummerJ1971The prevalence of chronic bronchitis, chronic airway obstruction, and respiratory symptoms in a Colorado cityAm Rev Respir Dis103209285100088
  • [MHLBI] National Heart, Lung and Blood Institute1998Morbidity and mortality: 1998 Chartbook on cardiovascular, lung, and blood diseasesBethesda MDUS Department, of Health and Human Services, Public Health Service, National Institutes of Health
  • NeffenHFritsherCSchachtFCAIRLA Survey Group2005Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) surveyRev Panam Salud Publica17191715826399
  • Ni ChroininMGreenstoneIRDucharmeFM2004Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adultsCochrane Database Syst Rev4CD005307
  • Ni ChroininMGreenstoneIRDanishA2005Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthmaCochrane Database Syst Rev4CD00553516235410
  • OostenbrinkJBRutten-van MölkenMPNoordJA2004One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonay diseaseEur Respir J23241914979498
  • OostenbrinkJBRutten-van MolkenMP2004Resource use and risks factors in high-cost exacerbations of COPDRespir Med9898839115338802
  • OttmaniSESherpbierRPioA2005Practical Approach to Lung Health (PAL): A primary health care strategy for the integrated management of respiratory conditions in people five years of age and overGenevaWorld Health OrganizationWHO/HTM/TB/2005.351.
  • PaggiaroPLDahleRBakranI1998Multicentre randomised placebo-controlled trial of inhaled fluticasone in patients with COPD. International COPD study groupLancet14773809519948
  • PereraBJ1995Efficacy and cost effectiveness of inhaled steroids in asthma in developing countriesArch Dis Child72312167763062
  • PriceMJBriggsAH2002Development of an economic model to assess the cost effectiveness of asthma management strategiesPharmaconeconomics2018394
  • RabeKFVermeirePASorianoJB2000Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J1680211153575
  • RabeKFAdachiMLaiCKW2004Worldwide severity and control of asthma in children and adults: the Global Asthma Insights and Reality SurveysJ Allergy Clin Immunol11440715241342
  • ReaHMcAuleySStewartA2004A chronic disease management programme can reduce days hospital for patients with COPDIntern Med J346081415546454
  • [SAPS] Working Group of the South African Pulmonary Society1998Guidelines for the management of chronic obstructive pulmonary diseaseSouth African Med J888
  • SchelledyDCMcCormickSRLeGrandTS2005The effect of a pediatric asthma management program provided by respiratory therapists and patient outcomes and costsHeart Lung34423816324962
  • SimonellaLMarksGSandersonK2006Cost-effectiveness of current and optimal treatment for adult asthmaIntern Med J3624416640742
  • SlamaKKarsentySHirschA1995Effectiveness of minimal intervention by general practitioners with their smoking patients: a randomised, controlled trial in FranceTob Control41629
  • SlamaK1998Tobacco control and prevention. A guide for low income countries. Paris: International Union against Tuberculosis and. Lung Disease. URL at http://www.iuatld.org/
  • SterkPJBuistSAWoolcockAJMarksGB1999The message from the 1998 World Asthma MeetingEur Respir J1414355310624779
  • [UNDP] United Nations Development Programme1997Human development report 1997. Human development to eradicate poverty [French]ParisEditions Economica
  • VanablePACareyMPBlairDC2006Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and womenAIDS Behav104738216604295
  • ViegiGPedreschiMPistelliF2000Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definitionChest1175 Suppl 2339S45S10843974
  • Von HertzenLReunanenAImpivaaraO2000Airway obstruction in relation to symptoms in chronic respiratory disease—a nationally representative population studyRespir Med943566310845434
  • WanAït-KhaledN2006Dissemination and implementation of Asthma Guidelines. State of the ArtInter J Tuberc Lung Dis1071016
  • WeissKBSullivanSD2001The health economics of asthma and rhinitis. Assessing the economic impactJ Allergy Clin Immunol1073811149982
  • World Bank1993World Development Report 1993: Investing in Health. World Bank Publication.
  • [WHO] World Health Organization1999Framework convention on tobacco control. Technical Briefing Series. WHO/NCD/TF1/99.1–7
  • [WHO] World Health Organization2004The World Health Report 2004: changing history. Statistical Annex 127–131GenevaWorld Health Organization
  • [WHO] World Health Organization2005Preventing chronic diseases: a vital investment [online]GenevaWorld Health Organization Accessed on November 8, 2006. URL: http://www.who.int/chp/chronic_disease_report/contents/en/index.html
  • WoutersEF2003Economic analysis of the confronting COPD survey: an overview of resultsRespir Med97suppl CS31412647938
  • YachD1996Le tabac en AfriqueForum Mondial de la Santé17308